Vascular Closure Devices Market by Type (Passive Approximators, Active Approximators, External Hemostatic Devices), Access (Femoral, Radial), Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery) - Global Forecast to 2026
The global vascular closure devices market is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 7.0% during the forecast period. The growth in this market can be attributed to a large number of approvals for vascular closure devices, high prevalence of cardiovascular diseases, increasing prevalence of obesity, increasing focus of market players on large-bore vascular closure devices, growing geriatric population, favorable reimbursement scenario for interventional radiology procedures, and rising focus on effective blood loss management in patients during surgeries. Emerging markets providing growth opportunities for market players and growth in the number of hospitals & surgical centers are expected to offer strong growth opportunities for players in the market. In contrast, the need for highly skilled professionals, risks associated with vascular closure devices, and stringent regulatory framework may challenge market growth to a certain extent. The vascular closure devices market is segmented based on type, access, procedure, and region.
“Passive approximators segment is expected to dominate the market during the forecast period.”
Based on type, the vascular closure devices market is segmented into passive approximators, active approximators, and external hemostatic devices. Passive approximators account for the largest share of the vascular closure devices market. The large share of this segment can be attributed to the increasing number of approvals for vascular closure devices and the wide range of advantages associated with these devices, such as ease of use and reduced complication rate in patients.
“Radial access segment to dominate the market during the forecast period.”
Based on access, the vascular closure devices market is segmented into radial access and femoral access. The femoral access segment commanded the largest share of the vascular closure devices market. . The large share of this segment can be attributed to the advantages of femoral access, such as better patient comfort, cost-effectiveness, and reduced hospitalization time.
“Interventional cardiology segment to dominate the market during the forecast period.”
Based on procedure, the vascular closure devices market is segmented into interventional cardiology procedures and interventional radiology/vascular surgery. Interventional cardiology for the largest share of the vascular closure devices market. The large share is attributed to the diagnosis and treatment of numerous cardiovascular disorders due to advancements in angioplasty and cardiac stenting and the growing prevalence of cardiac disorders globally.
“North America will dominate the market during the forecast period.”
The global vascular closure devices market is segmented into North America (the US and Canada), Europe (E-3, and the Rest of Europe), Asia Pacific, and Rest of World. In 2020, North America dominated the global vascular closure devices market, followed by Europe. The large share of the North American market can be attributed to the rising prevalence of cardiovascular diseases, the growing trend of one-day surgeries for vascular procedures, increasing research and clinical trials for vascular closure devices in the US, the increasing number of cardiac arrest cases, and the long waiting periods for cardiac surgeries (which encourage the adoption of minimally invasive procedures) in Canada.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the global vascular closure devices market. It aims at estimating the size and future growth potential of the market across different segments, such as type, access, procedure and region. The report also analyzes factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total vascular closure devices market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
“Passive approximators segment is expected to dominate the market during the forecast period.”
Based on type, the vascular closure devices market is segmented into passive approximators, active approximators, and external hemostatic devices. Passive approximators account for the largest share of the vascular closure devices market. The large share of this segment can be attributed to the increasing number of approvals for vascular closure devices and the wide range of advantages associated with these devices, such as ease of use and reduced complication rate in patients.
“Radial access segment to dominate the market during the forecast period.”
Based on access, the vascular closure devices market is segmented into radial access and femoral access. The femoral access segment commanded the largest share of the vascular closure devices market. . The large share of this segment can be attributed to the advantages of femoral access, such as better patient comfort, cost-effectiveness, and reduced hospitalization time.
“Interventional cardiology segment to dominate the market during the forecast period.”
Based on procedure, the vascular closure devices market is segmented into interventional cardiology procedures and interventional radiology/vascular surgery. Interventional cardiology for the largest share of the vascular closure devices market. The large share is attributed to the diagnosis and treatment of numerous cardiovascular disorders due to advancements in angioplasty and cardiac stenting and the growing prevalence of cardiac disorders globally.
“North America will dominate the market during the forecast period.”
The global vascular closure devices market is segmented into North America (the US and Canada), Europe (E-3, and the Rest of Europe), Asia Pacific, and Rest of World. In 2020, North America dominated the global vascular closure devices market, followed by Europe. The large share of the North American market can be attributed to the rising prevalence of cardiovascular diseases, the growing trend of one-day surgeries for vascular procedures, increasing research and clinical trials for vascular closure devices in the US, the increasing number of cardiac arrest cases, and the long waiting periods for cardiac surgeries (which encourage the adoption of minimally invasive procedures) in Canada.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type - Tier 1: 52%, Tier 2: 30% and Tier 3: 18%
- By Designation - C-level: 45%, D-level: 30%, and Others: 25%
- By Region - North America: 36%, Europe: 24%, Asia Pacific: 29%, and Rest of World: 11%
- Terumo Corporation (Japan)
- Abbott (US)
- Cardinal Health (US)
- Cardiva Medical, Inc. (US)
- Medtronic Plc (Ireland)
- Morris Innovative, Inc. (US)
- Teleflex Incorporated (US)
- Merit Medical Systems, Inc. (US)
- Vasorum Ltd. (Ireland)
- TZ Medical, Inc. (US)
- Vivasure Medical Ltd. (Ireland)
- Tricol Biomedical (US)
- Scion Biomedical (US)
- Advanced Vascular Dynamics (US)
- Marine Polymer Technologies, Inc. (US)
- Transluminal Technologies (US)
- Rex Medical (US)
- Meril Life Sciences Pvt. Ltd. (India)
- Medas USA (US)
- Vygon Company (France)
This report provides a detailed picture of the global vascular closure devices market. It aims at estimating the size and future growth potential of the market across different segments, such as type, access, procedure and region. The report also analyzes factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total vascular closure devices market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on vascular closure devices offered by the top 20 players in the vascular closure devices market. The report analyses the vascular closure devices market by type, access, procedure and region.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various vascular closure devices across key geographic regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular closure devices market.
- Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the vascular closure devices market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
FIGURE 1 VASCULAR CLOSURE DEVICES MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.2 SECONDARY DATA
2.2.1 SECONDARY SOURCES
2.3 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.3.2 KEY INDUSTRY INSIGHTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.4 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.4.1 GROWTH FORECAST
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 TOP-DOWN APPROACH
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.6 MARKET SHARE ANALYSIS
2.7 ASSUMPTIONS FOR THE STUDY
2.7.1 COVID-19-SPECIFIC ASSUMPTIONS
2.8 LIMITATIONS
2.9 RISK ASSESSMENT
2.10 COVID-19 ECONOMIC ASSESSMENT
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY
FIGURE 11 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 12 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021 VS. 2026 (USD MILLION)
FIGURE 13 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 VASCULAR CLOSURE DEVICES MARKET OVERVIEW
FIGURE 15 LARGE NUMBER OF APPROVALS FOR VASCULAR CLOSURE DEVICES TO DRIVE MARKET GROWTH
4.2 VASCULAR CLOSURE DEVICES MARKET, BY TYPE (2021–2026)
FIGURE 16 PASSIVE APPROXIMATORS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE AND COUNTRY (2020)
FIGURE 17 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN VASCULAR CLOSURE DEVICES MARKET IN 2020
4.4 VASCULAR CLOSURE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 US TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
FIGURE 19 VASCULAR CLOSURE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing approvals of vascular closure devices
TABLE 1 APPROVALS OF VASCULAR CLOSURE DEVICES
5.2.1.2 High prevalence of cardiovascular diseases
5.2.1.3 Increasing prevalence of obesity
5.2.1.4 Increasing focus of market players on large-bore vascular closure devices
5.2.1.5 Growing geriatric population
5.2.1.6 Favorable reimbursement scenario for interventional radiology procedures
TABLE 2 REIMBURSEMENTS FOR INTERVENTIONAL RADIOLOGY PROCEDURES IN THE US
5.2.1.7 Rising focus on effective blood loss management in patients during surgeries
5.2.1.8 Increasing investments, funds, and grants for research on vascular devices
5.2.2 RESTRAINTS
5.2.2.1 Increasing preference for interventional procedures using radial artery access
5.2.2.2 High cost of vascular closure devices
5.2.2.3 Product recalls and failures
TABLE 3 RECENT RECALLS OF VASCULAR CLOSURE DEVICES
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets providing growth opportunities for market players
5.2.3.2 Growth in the number of hospitals & surgical centers
5.2.4 CHALLENGES
5.2.4.1 Need for highly skilled professionals
5.2.4.2 Risks associated with vascular closure devices
5.2.4.3 Stringent regulatory frameworks
5.3 COVID-19 IMPACT ON THE VASCULAR CLOSURE DEVICES MARKET
6 VASCULAR CLOSURE DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 4 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 5 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
6.2 PASSIVE APPROXIMATORS
TABLE 6 PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 7 PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 8 PASSIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 9 PASSIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.2.1 COLLAGEN PLUGS
6.2.1.1 Growing number of approvals for collagen-based vascular closure devices to drive market growth during the forecast period
TABLE 10 COLLAGEN PLUGS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 11 COLLAGEN PLUGS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.2.2 SEALANT OR GEL-BASED DEVICES
6.2.2.1 Sealant or gel-based devices to register the highest growth rate during the forecast period
TABLE 12 SEALANT OR GEL-BASED DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 13 SEALANT OR GEL-BASED DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
6.2.3 COMPRESSION ASSIST DEVICES
6.2.3.1 Compression assist devices do not leave behind any foreign body in the tissue artery—a major advantage of these devices
TABLE 14 COMPRESSION ASSIST DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 15 COMPRESSION ASSIST DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
6.3 ACTIVE APPROXIMATORS
TABLE 16 ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 17 ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 18 ACTIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 19 ACTIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.3.1 SUTURE-BASED DEVICES
6.3.1.1 Increasing applications of suture-based devices to
favor market growth
TABLE 20 SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 21 SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.3.2 CLIP-BASED DEVICES
6.3.2.1 Growing innovation in the field of clip-based devices to aid market growth
TABLE 22 CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 23 CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.4 EXTERNAL HEMOSTATIC DEVICES
6.4.1 RISING ADOPTION OF MINIMALLY INVASIVE THERAPEUTIC PROCEDURES TO DRIVE MARKET GROWTH
TABLE 24 EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 25 EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
7 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS
7.1 INTRODUCTION
TABLE 26 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 27 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
7.2 FEMORAL ACCESS
7.2.1 ADVANTAGES ASSOCIATED WITH FEMORAL ACCESS, SUCH AS GREATER COMFORT LEVEL FOR PATIENTS AND REDUCED COST OF HOSPITALIZATION, TO DRIVE MARKET GROWTH
TABLE 28 FEMORAL ACCESS: RESEARCH STUDIES
TABLE 29 FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 30 FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
7.3 RADIAL ACCESS
7.3.1 TRANSRADIAL APPROACH REDUCES VASCULAR COMPLICATIONS COMPARED TO THE FEMORAL ARTERY ACCESS APPROACH—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 31 RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 32 RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
8 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE
8.1 INTRODUCTION
TABLE 33 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 34 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
8.2 INTERVENTIONAL CARDIOLOGY
8.2.1 ASSOCIATED BENEFITS OF INTERVENTIONAL CARDIOLOGY PROCEDURES, SUCH AS REDUCED SCARRING AND LESS PAIN, TO DRIVE MARKET GROWTH
TABLE 35 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2017–2020 (USD MILLION)
TABLE 36 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2021–2026 (USD MILLION)
8.3 INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY
8.3.1 GROWTH IN THE PREVALENCE OF PAD IS INCREASING THE DEMAND FOR ENDOVASCULAR INTERVENTIONAL PROCEDURES
TABLE 37 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION, 2017–2020 (USD MILLION)
TABLE 38 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION, 2021–2026 (USD MILLION)
9 VASCULAR CLOSURE DEVICES MARKET, BY REGION
9.1 INTRODUCTION
TABLE 39 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 40 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT
TABLE 41 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 42 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 43 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 44 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 45 NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 46 NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 47 NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 48 NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 49 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 50 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 52 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American vascular closure
devices market
TABLE 53 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 2020
TABLE 54 US: KEY MACROINDICATORS
TABLE 55 US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 56 US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 57 US: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 58 US: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 59 US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 60 US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 61 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 62 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 63 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 64 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising prevalence of target diseases to drive market growth
TABLE 65 CANADA: KEY MACROINDICATORS
TABLE 66 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 67 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 68 CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 69 CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 70 CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 71 CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 72 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 73 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 74 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 75 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.3 EUROPE
TABLE 76 NUMBER OF SURGICAL PROCEDURES PER 100,000 POPULATION, BY COUNTRY, 2018
TABLE 77 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 78 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 79 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 80 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 81 EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 82 EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 83 EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 84 EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 85 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 86 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 87 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 88 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.3.1 E-3
9.3.1.1 Increase in number of radial procedures to boost the market demand
TABLE 89 GERMANY: KEY MACROINDICATORS
TABLE 90 UK: KEY MACROINDICATORS
TABLE 91 FRANCE: KEY MACROINDICATORS
TABLE 92 E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 93 E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 94 E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 95 E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 96 E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 97 E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 98 E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 99 E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 100 E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 101 E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.3.2 REST OF EUROPE
TABLE 102 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
TABLE 103 ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 104 ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 105 ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 106 ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 107 ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 108 ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 109 ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 110 ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 111 ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 112 ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 INCREASING HEALTH EXPENDITURE TO DRIVE MARKET GROWTH IN APAC
FIGURE 21 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT
TABLE 113 CHINA: KEY MACROINDICATORS
TABLE 114 JAPAN: KEY MACROINDICATORS
TABLE 115 INDIA: KEY INDICATORS
TABLE 116 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 117 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 119 ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 120 ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 121 ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 122 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 123 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 124 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 125 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.5 REST OF THE WORLD
9.5.1 GOVERNMENT INITIATIVES TO PROMOTE HEALTHCARE SERVICES TO SUPPORT MARKET GROWTH
TABLE 126 ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 127 ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 128 ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 129 ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 130 ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 131 ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 132 ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 133 ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 134 ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 135 ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 136 OVERVIEW OF STRATEGIES ADOPTED BY KEY VASCULAR CLOSURE DEVICES MARKET PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 22 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE VASCULAR CLOSURE DEVICES MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 23 VASCULAR CLOSURE DEVICES MARKET SHARE ANALYSIS, 2020
TABLE 137 VASCULAR CLOSURE DEVICES MARKET: DEGREE OF COMPETITION (2020)
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 24 VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION
QUADRANT (2020)
10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 25 VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS (2020)
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 138 PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
TABLE 139 DEALS
10.7.3 OTHER DEVELOPMENTS
TABLE 140 OTHER DEVELOPMENTS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 TERUMO CORPORATION
TABLE 141 TERUMO CORPORATION: BUSINESS OVERVIEW
FIGURE 26 TERUMO CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 142 EXCHANGE RATES (USED FOR THE CONVERSION OF YEN TO USD)
11.1.2 ABBOTT LABORATORIES
TABLE 143 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
11.1.3 CARDINAL HEALTH
TABLE 144 CARDINAL HEALTH: BUSINESS OVERVIEW
FIGURE 28 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
11.1.4 CARDIVA MEDICAL, INC.
TABLE 145 CARDIVA MEDICAL, INC.: BUSINESS OVERVIEW
11.1.5 MEDTRONIC PLC
TABLE 146 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 29 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.6 MORRIS INNOVATIVE, INC.
TABLE 147 MORRIS INNOVATIVE, INC.: BUSINESS OVERVIEW
11.1.7 TELEFLEX INCORPORATED
TABLE 148 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
FIGURE 30 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020)
11.1.8 MERIT MEDICAL SYSTEMS, INC.
TABLE 149 MERIT MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
FIGURE 31 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020)
11.1.9 VASORUM LTD.
TABLE 150 VASORUM LTD.: BUSINESS OVERVIEW
11.1.10 TZ MEDICAL, INC.
TABLE 151 TZ MEDICAL INC.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 VIVASURE MEDICAL LTD.
11.2.2 TRICOL BIOMEDICAL
11.2.3 SCION BIOMEDICAL
11.2.4 ADVANCED VASCULAR DYNAMICS
11.2.5 MARINE POLYMER TECHNOLOGIES, INC.
11.2.6 TRANSLUMINAL TECHNOLOGIES
11.2.7 REX MEDICAL
11.2.8 MERIL LIFE SCIENCES PVT. LTD.
11.2.9 MEDAS USA
11.2.10 VYGON COMPANY
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
FIGURE 1 VASCULAR CLOSURE DEVICES MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.2 SECONDARY DATA
2.2.1 SECONDARY SOURCES
2.3 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.3.2 KEY INDUSTRY INSIGHTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.4 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.4.1 GROWTH FORECAST
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 TOP-DOWN APPROACH
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.6 MARKET SHARE ANALYSIS
2.7 ASSUMPTIONS FOR THE STUDY
2.7.1 COVID-19-SPECIFIC ASSUMPTIONS
2.8 LIMITATIONS
2.9 RISK ASSESSMENT
2.10 COVID-19 ECONOMIC ASSESSMENT
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY
FIGURE 11 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 12 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021 VS. 2026 (USD MILLION)
FIGURE 13 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 VASCULAR CLOSURE DEVICES MARKET OVERVIEW
FIGURE 15 LARGE NUMBER OF APPROVALS FOR VASCULAR CLOSURE DEVICES TO DRIVE MARKET GROWTH
4.2 VASCULAR CLOSURE DEVICES MARKET, BY TYPE (2021–2026)
FIGURE 16 PASSIVE APPROXIMATORS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE AND COUNTRY (2020)
FIGURE 17 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN VASCULAR CLOSURE DEVICES MARKET IN 2020
4.4 VASCULAR CLOSURE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 US TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
FIGURE 19 VASCULAR CLOSURE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing approvals of vascular closure devices
TABLE 1 APPROVALS OF VASCULAR CLOSURE DEVICES
5.2.1.2 High prevalence of cardiovascular diseases
5.2.1.3 Increasing prevalence of obesity
5.2.1.4 Increasing focus of market players on large-bore vascular closure devices
5.2.1.5 Growing geriatric population
5.2.1.6 Favorable reimbursement scenario for interventional radiology procedures
TABLE 2 REIMBURSEMENTS FOR INTERVENTIONAL RADIOLOGY PROCEDURES IN THE US
5.2.1.7 Rising focus on effective blood loss management in patients during surgeries
5.2.1.8 Increasing investments, funds, and grants for research on vascular devices
5.2.2 RESTRAINTS
5.2.2.1 Increasing preference for interventional procedures using radial artery access
5.2.2.2 High cost of vascular closure devices
5.2.2.3 Product recalls and failures
TABLE 3 RECENT RECALLS OF VASCULAR CLOSURE DEVICES
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets providing growth opportunities for market players
5.2.3.2 Growth in the number of hospitals & surgical centers
5.2.4 CHALLENGES
5.2.4.1 Need for highly skilled professionals
5.2.4.2 Risks associated with vascular closure devices
5.2.4.3 Stringent regulatory frameworks
5.3 COVID-19 IMPACT ON THE VASCULAR CLOSURE DEVICES MARKET
6 VASCULAR CLOSURE DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 4 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 5 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
6.2 PASSIVE APPROXIMATORS
TABLE 6 PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 7 PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 8 PASSIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 9 PASSIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.2.1 COLLAGEN PLUGS
6.2.1.1 Growing number of approvals for collagen-based vascular closure devices to drive market growth during the forecast period
TABLE 10 COLLAGEN PLUGS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 11 COLLAGEN PLUGS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.2.2 SEALANT OR GEL-BASED DEVICES
6.2.2.1 Sealant or gel-based devices to register the highest growth rate during the forecast period
TABLE 12 SEALANT OR GEL-BASED DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 13 SEALANT OR GEL-BASED DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
6.2.3 COMPRESSION ASSIST DEVICES
6.2.3.1 Compression assist devices do not leave behind any foreign body in the tissue artery—a major advantage of these devices
TABLE 14 COMPRESSION ASSIST DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 15 COMPRESSION ASSIST DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
6.3 ACTIVE APPROXIMATORS
TABLE 16 ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 17 ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 18 ACTIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 19 ACTIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.3.1 SUTURE-BASED DEVICES
6.3.1.1 Increasing applications of suture-based devices to
favor market growth
TABLE 20 SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 21 SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.3.2 CLIP-BASED DEVICES
6.3.2.1 Growing innovation in the field of clip-based devices to aid market growth
TABLE 22 CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 23 CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.4 EXTERNAL HEMOSTATIC DEVICES
6.4.1 RISING ADOPTION OF MINIMALLY INVASIVE THERAPEUTIC PROCEDURES TO DRIVE MARKET GROWTH
TABLE 24 EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 25 EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
7 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS
7.1 INTRODUCTION
TABLE 26 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 27 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
7.2 FEMORAL ACCESS
7.2.1 ADVANTAGES ASSOCIATED WITH FEMORAL ACCESS, SUCH AS GREATER COMFORT LEVEL FOR PATIENTS AND REDUCED COST OF HOSPITALIZATION, TO DRIVE MARKET GROWTH
TABLE 28 FEMORAL ACCESS: RESEARCH STUDIES
TABLE 29 FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 30 FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
7.3 RADIAL ACCESS
7.3.1 TRANSRADIAL APPROACH REDUCES VASCULAR COMPLICATIONS COMPARED TO THE FEMORAL ARTERY ACCESS APPROACH—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 31 RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 32 RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
8 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE
8.1 INTRODUCTION
TABLE 33 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 34 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
8.2 INTERVENTIONAL CARDIOLOGY
8.2.1 ASSOCIATED BENEFITS OF INTERVENTIONAL CARDIOLOGY PROCEDURES, SUCH AS REDUCED SCARRING AND LESS PAIN, TO DRIVE MARKET GROWTH
TABLE 35 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2017–2020 (USD MILLION)
TABLE 36 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2021–2026 (USD MILLION)
8.3 INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY
8.3.1 GROWTH IN THE PREVALENCE OF PAD IS INCREASING THE DEMAND FOR ENDOVASCULAR INTERVENTIONAL PROCEDURES
TABLE 37 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION, 2017–2020 (USD MILLION)
TABLE 38 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION, 2021–2026 (USD MILLION)
9 VASCULAR CLOSURE DEVICES MARKET, BY REGION
9.1 INTRODUCTION
TABLE 39 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 40 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT
TABLE 41 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 42 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 43 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 44 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 45 NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 46 NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 47 NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 48 NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 49 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 50 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 52 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American vascular closure
devices market
TABLE 53 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 2020
TABLE 54 US: KEY MACROINDICATORS
TABLE 55 US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 56 US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 57 US: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 58 US: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 59 US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 60 US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 61 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 62 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 63 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 64 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising prevalence of target diseases to drive market growth
TABLE 65 CANADA: KEY MACROINDICATORS
TABLE 66 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 67 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 68 CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 69 CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 70 CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 71 CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 72 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 73 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 74 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 75 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.3 EUROPE
TABLE 76 NUMBER OF SURGICAL PROCEDURES PER 100,000 POPULATION, BY COUNTRY, 2018
TABLE 77 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 78 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 79 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 80 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 81 EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 82 EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 83 EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 84 EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 85 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 86 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 87 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 88 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.3.1 E-3
9.3.1.1 Increase in number of radial procedures to boost the market demand
TABLE 89 GERMANY: KEY MACROINDICATORS
TABLE 90 UK: KEY MACROINDICATORS
TABLE 91 FRANCE: KEY MACROINDICATORS
TABLE 92 E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 93 E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 94 E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 95 E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 96 E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 97 E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 98 E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 99 E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 100 E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 101 E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.3.2 REST OF EUROPE
TABLE 102 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
TABLE 103 ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 104 ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 105 ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 106 ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 107 ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 108 ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 109 ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 110 ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 111 ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 112 ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 INCREASING HEALTH EXPENDITURE TO DRIVE MARKET GROWTH IN APAC
FIGURE 21 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT
TABLE 113 CHINA: KEY MACROINDICATORS
TABLE 114 JAPAN: KEY MACROINDICATORS
TABLE 115 INDIA: KEY INDICATORS
TABLE 116 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 117 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 119 ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 120 ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 121 ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 122 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 123 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 124 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 125 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
9.5 REST OF THE WORLD
9.5.1 GOVERNMENT INITIATIVES TO PROMOTE HEALTHCARE SERVICES TO SUPPORT MARKET GROWTH
TABLE 126 ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 127 ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 128 ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 129 ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 130 ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 131 ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 132 ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION)
TABLE 133 ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION)
TABLE 134 ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION)
TABLE 135 ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 136 OVERVIEW OF STRATEGIES ADOPTED BY KEY VASCULAR CLOSURE DEVICES MARKET PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 22 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE VASCULAR CLOSURE DEVICES MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 23 VASCULAR CLOSURE DEVICES MARKET SHARE ANALYSIS, 2020
TABLE 137 VASCULAR CLOSURE DEVICES MARKET: DEGREE OF COMPETITION (2020)
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 24 VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION
QUADRANT (2020)
10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 25 VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS (2020)
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 138 PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
TABLE 139 DEALS
10.7.3 OTHER DEVELOPMENTS
TABLE 140 OTHER DEVELOPMENTS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 TERUMO CORPORATION
TABLE 141 TERUMO CORPORATION: BUSINESS OVERVIEW
FIGURE 26 TERUMO CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 142 EXCHANGE RATES (USED FOR THE CONVERSION OF YEN TO USD)
11.1.2 ABBOTT LABORATORIES
TABLE 143 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
11.1.3 CARDINAL HEALTH
TABLE 144 CARDINAL HEALTH: BUSINESS OVERVIEW
FIGURE 28 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
11.1.4 CARDIVA MEDICAL, INC.
TABLE 145 CARDIVA MEDICAL, INC.: BUSINESS OVERVIEW
11.1.5 MEDTRONIC PLC
TABLE 146 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 29 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.6 MORRIS INNOVATIVE, INC.
TABLE 147 MORRIS INNOVATIVE, INC.: BUSINESS OVERVIEW
11.1.7 TELEFLEX INCORPORATED
TABLE 148 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
FIGURE 30 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020)
11.1.8 MERIT MEDICAL SYSTEMS, INC.
TABLE 149 MERIT MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
FIGURE 31 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020)
11.1.9 VASORUM LTD.
TABLE 150 VASORUM LTD.: BUSINESS OVERVIEW
11.1.10 TZ MEDICAL, INC.
TABLE 151 TZ MEDICAL INC.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 VIVASURE MEDICAL LTD.
11.2.2 TRICOL BIOMEDICAL
11.2.3 SCION BIOMEDICAL
11.2.4 ADVANCED VASCULAR DYNAMICS
11.2.5 MARINE POLYMER TECHNOLOGIES, INC.
11.2.6 TRANSLUMINAL TECHNOLOGIES
11.2.7 REX MEDICAL
11.2.8 MERIL LIFE SCIENCES PVT. LTD.
11.2.9 MEDAS USA
11.2.10 VYGON COMPANY
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
